Kynapcin-28, identified by its CAS number 476337-33-4, is a synthetic compound that belongs to a class of substances known for their potential pharmacological properties. While specific characteristics such as molecular weight, structure, and solubility may vary, compounds in this category often exhibit biological activity, potentially influencing various physiological processes. Kynapcin-28 may be studied for its effects on cellular pathways, receptor interactions, or as a lead compound in drug development. Its safety profile, including toxicity and pharmacokinetics, would be critical for evaluating its suitability for therapeutic applications. As with many synthetic compounds, detailed studies are necessary to fully understand its mechanism of action, efficacy, and potential side effects. Research on Kynapcin-28 may also explore its applications in fields such as medicinal chemistry or biochemistry, contributing to the broader understanding of similar compounds and their roles in health and disease.

Kynapcin-28

476337-33-4: Kynapcin-28, identified by its CAS number 476337-33-4, is a synthetic compound that belongs to a class of substances known for their potential pharmacological properties. While specific characteristics such as molecular weight, structure, and solubility may vary, compounds in this category often exhibit biological activity, potentially influencing various physiological processes. Kynapcin-28 may be studied for its effects on cellular pathways, receptor interactions, or as a lead compound in drug development. Its safety profile, including toxicity and pharmacokinetics, would be critical for evaluating its suitability for therapeutic applications. As with many synthetic compounds, detailed studies are necessary to fully understand its mechanism of action, efficacy, and potential side effects. Research on Kynapcin-28 may also explore its applications in fields such as medicinal chemistry or biochemistry, contributing to the broader understanding of similar compounds and their roles in health and disease.

<p>Kynapcin-28 is a non-competitive inhibitor of prolyl endopeptidase (PEP) with an IC50 of 76.80 μM and exhibits weak inhibitory effects on other serine proteases.</p>

CAS 476337-33-4

Kynapcin-28

Kynapcin-28

Ref: TM-TN10542